Revenue segments as reported by the company.

Premiums earned, net

Other income

Investment income, net

Direct Contracting revenue

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Net medical claims incurred

Salaries and benefits

General and administrative expenses

Premium deficiency reserve (benefit) expense

Depreciation and amortization

Other expense

Restructuring costs

Impairment of goodwill and other intangible assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Clover Health Investments

Clover Health Investments Corp. provides healthcare insurance services. It uses its proprietary technology platform to collect, structure, and analyze health and behavioral data to improve medical outcomes and lower costs for patients. The company was founded on July 17, 2014 and is headquartered in Franklin, TN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Clover Health reports profitable Q1, poised for sustained growth

Clover Health Investments had a strong Q1 performance, expecting full-year profitability and revenue growth. With a focus on operational enhancements, revenue growth, and cost reductions, the company aims to maintain momentum in 2024 amidst industry challenges. Clover's strategic initiatives like share repurchase program and product enhancements position it well for sustained growth and care management excellence.

Clover Health achieves profitability milestone and eyes market expansion

Clover Health's Q2 2024 earnings call reflects a positive trajectory with increased profitability, strong revenue growth, and improved guidance for the full year.
The company's strategic focus on operational efficiency, technology innovation, and market validation positions it well for sustainable growth and market expansion.
While facing challenges in maintaining profitability and implementing technology enhancements, Clover Health has opportunities to capitalize on market interest and drive further growth in the Medicare Advantage sector.

Clover Health reports strong Q3 performance and eyes growth opportunities

Clover Health Investments (CLOV) showcased strong financial performance and strategic investments in growth areas during the Q3 2024 earnings call. The company's focus on membership growth, quality initiatives, and technology enhancements, along with exploring health partnerships, highlights a promising outlook for future success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Clover Health Investments Corp. is a physician enablement technology company that provides Medicare Advantage plans in the United States. Its strategy is powered by its proprietary software platform, Clover Assistant, which aggregates patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic diseases. The company offers PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. Clover Health Investments was founded by Vivek Garipalli and Andrew Toy on July 17, 2014 and is headquartered in Franklin, TN.

Clover Health Investments, Corp. (NASDAQ:CLOV ) Q3 2023 Earnings Conference Call November 6, 2023 5:00 PM ET Company Participants Ryan Schmidt - IR Andrew Toy - CEO Scott Leffler - CFO Conference Call Participants Jason Cassorla - Citi John Pinney - Canaccord Genuity Operator Ladies and gentlemen, good afternoon, and welcome to the Clover Health Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.

Clover Health Investments, Corp. (CLOV) Q3 2023 Earnings Call Transcript

Q3 2023 Insurance MCR Improved to 78.5% , bringing year-to-date MCR to 80.8% , and Insurance revenue grew 12% compared to Q3 2022

Clover Health Reports Third Quarter 2023 Results; Highlights Continued Improvement in Financial Performance and Improved 2023 Guidance

FRANKLIN, Tenn., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Clover Health (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced the appointment of Karen Soares as General Counsel, effective October 31, 2023. Karen will serve on Clover's management team and will report to Andrew Toy, Chief Executive Officer of Clover.

Clover Health Promotes Karen Soares to General Counsel

Innovage Holding Corp

UnitedHealth Group

The recent strikes by Kaiser Permanente workers speak to greater structural issues that threaten weaker healthcare stocks in general. It's clear that healthcare firms are increasingly under greater pressure to improve working conditions.

3 Healthcare Stocks to Sell Before Unionization Hurts Profits

FRANKLIN, Tenn., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that it will report third quarter 2023 financial results after market close on Monday, November 6, 2023. Management will host a conference call and webcast at 5:00 p.m. Eastern Time on November 6, 2023 to discuss the Company's business and financial results.

Clover Health to Report Third Quarter 2023 Financial Results on November 6, 2023

Retrospective data analysis covering forty-four thousand patients and over eight thousand primary care practitioners finds clinicians using Clover Assistant identify and treat diabetes earlier in its progression, changing the trajectory of illness. Results were similar even when restricting analysis to the same provider before and after their adoption of Clover Assistant. Retrospective data analysis covering forty-four thousand patients and over eight thousand primary care practitioners finds clinicians using Clover Assistant identify and treat diabetes earlier in its progression, changing the trajectory of illness. Results were similar even when restricting analysis to the same provider before and after their adoption of Clover Assistant.

Clinician Use of Clover Assistant is Associated with Earlier Identification and Management of Diabetes

Here is how Clover Health Investments, Corp. (CLOV) and Amedisys (AMED) have performed compared to their sector so far this year.

Are Medical Stocks Lagging Clover Health Investments (CLOV) This Year?

Bristol-Myers

Moderna

Healthcare stocks generally offer a lot of upside. The cost of healthcare is incredibly expensive in the United States and the companies that deliver it tend to do very well overall.

Beware! 3 Healthcare Stocks Waving Massive Red Flags Right Now.

FRANKLIN, Tenn., Sept. 22, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving health equity for seniors, today announced that its CEO, Andrew Toy, will participate in a fireside chat during the Maxim Group Emerging Growth in A.I. Virtual Conference on Tuesday, September 26, 2023, at 5:00 p.m. Eastern Time.

Clover Health to Present at Maxim Group Emerging Growth in A.I. Virtual Conference on September 26, 2023

FRANKLIN, Tenn., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that it will host a virtual Clover Assistant Showcase on Thursday, October 12, 2023 at 12:00 p.m. Eastern Time. The event will feature informative product demonstrations, followed by a live Q&A session with Clover executives and key members of the Clover Assistant team.

Clover Health to Host Virtual Clover Assistant Showcase on October 12, 2023

Clover Health (NASDAQ: CLOV) stock price has pulled back in the past few days as the recent uptrend eased. The shares were trading at $1.30 on Thursday, lower than this month's high of $1.63.

Clover Health stock price could jump by 54% if this happens

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Clover Health Investments, Corp. (CLOV) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

Clover Health Investments, Corp. (CLOV) Shows Fast-paced Momentum But Is Still a Bargain Stock

Clover Health beat analysts' estimates in Q2. The company also raised the lower end of its full-year insurance revenue guidance range.

Why Clover Health Stock Is Soaring Today

Clover Health Investments, Corp. (CLOV) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to loss of $0.22 per share a year ago.

Clover Health Investments, Corp. (CLOV) Reports Q2 Loss, Tops Revenue Estimates

Insurance revenue grew 17% compared to Q2'22, and second quarter Insurance MCR improved to 77.2% , bringing first half MCR to 81.9%

Clover Health Reports Strong Second Quarter 2023 Results; Highlights Improved Financial Performance and Guidance Ranges

FRANKLIN, Tenn., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to improving health equity for seniors, today announced its participation in the following investor conferences:

Clover Health to Present at Canaccord Genuity 43rd Annual Growth Conference and 2023 Wells Fargo Healthcare Conference

Retrospective data analysis covering seven thousand patients and over two thousand primary care providers finds clinicians using Clover Assistant identify and treat CKD Stage 3 earlier in its progression, changing the trajectory of illness. Results were the same even when restricting analysis to the same provider before and after their adoption of Clover Assistant. Retrospective data analysis covering seven thousand patients and over two thousand primary care providers finds clinicians using Clover Assistant identify and treat CKD Stage 3 earlier in its progression, changing the trajectory of illness. Results were the same even when restricting analysis to the same provider before and after their adoption of Clover Assistant.

Clinician Use of Clover Assistant is Associated with Significant Improvement in the Early Identification and Management of Chronic Kidney Disease

The healthcare insurer specializes in Medicare Advantage plans. The stock is likely no longer in danger of being delisted from the NASDAQ.

Why Shares of Clover Health Jumped This Week

CleanSpark

FuelCell Energy

Marathon Digital Holdings

Nikola

SoundHound AI Inc

Virgin Galactic

WeWork

It's been a tough year for those in the business of shorting stocks, as a feared recession hasn't arrived, which has allowed the beaten-down of Corporate America to survive, if perhaps not thrive. According to HFR, hedge funds have returned just 3% this year, which makes sense given the terrible results for managers who are shorting securities.

It's a dash for trash right now, and these lotto stocks have rocketed 86% on average

FRANKLIN, Tenn., July 11, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that it will report second quarter 2023 financial results after market close on Tuesday, August 8, 2023. On that day management will host a conference call and webcast at 5:00 p.m. Eastern Time to discuss the Company's business and financial results.

Clover Health to Report Second Quarter 2023 Financial Results on August 8, 2023

The health insurer is having trouble adding to its membership base. If its software succeeds in helping stakeholders to cut costs, that might change.

Clover Health Is Down 68% In 1 Year, But Wall Street Is Predicting It'll Rise by 70%. Should You Buy It?

Augmedix

Definitive Healthcare Corp

Zacks Medical Info Systems industry stocks like Definitive Healthcare (DH), Clover Health Investments (CLOV) and Augmedix (AUGX) are expected to gain from new normal trends.

3 Medical Info Systems Stocks to Consider From a Prospering Industry

Fast-paced Momentum Stock Clover Health Investments, Corp. (CLOV) Is Still Trading at a Bargain

FRANKLIN, Tenn., June 22, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that the Company has reached an agreement in principle to resolve seven derivative lawsuits pending in Delaware, New York, and Tennessee courts (collectively, the “derivative lawsuits”). The proposed derivative settlement contains no admission of liability or wrongdoing by any of the defendants and is subject to definitive documentation and final court approval. Along with the settlement of the securities class action described in the Company's April 24, 2023 press release, the Company has now reached settlements for all of the outstanding civil litigation that was filed following its de-SPAC transaction.

Clover Health Announces Agreement to Settle Derivative Litigation, Resolving All Remaining Civil Litigation Relating to its de-SPAC Transaction

Faraday Future Intelligent Electric

With the stock market surging, investors are looking at more speculative opportunities for outsized gains. But investors should be careful with low-priced equities, and in particular these three overvalued penny stocks.

News for Clover Health Investments Stock (CLOV)